3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Breast Neoplasms
3499
Neoplasms
2740
Prostatic Neoplasms
1583
Colorectal Neoplasms
1248
Lung Neoplasms
1188
Motor Activity
766
Head and Neck Neoplasms
621
Pancreatic Neoplasms
601
Colonic Neoplasms
586
Uterine Cervical Neoplasms
567
Carcinoma, Non-Small-Cell Lung
560
Carcinoma, Hepatocellular
559
Rectal Neoplasms
516
Stomach Neoplasms
493
Brain Neoplasms
438
Anxiety Disorders
401
Ovarian Neoplasms
399
Pain
376
Esophageal Neoplasms
347
Polycystic Ovary Syndrome
341
Neoplasm Metastasis
340
Fatigue
324
Urinary Bladder Neoplasms
314
Precursor Cell Lymphoblastic Leukemia-Lymphoma
303
Melanoma
298
Depression
286
Multiple Myeloma
283
Endometrial Neoplasms
263
Lymphoma
258
Hematologic Neoplasms
251
Interventions
posaconazole
1
Fluconazole
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
OTHER
×
Aspergillosis
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled
NCT02955966
2025-11-20
OPTIFIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
51 enrolled